Table 4.
China16 | Hong Kong17 | India18 | South Korea19 | Taiwan20 | Thailand21 | Total‡ | |
G1, % | 22.4 | 42.6 | 27.7 | 52 | 41 | 1.0 | 32 |
G2, % | 0.2 | 15.5 | 31.0 | 7.5 | 8.0 | 17.0 | 14 |
G3, % | 63.3 | 30.7 | 0 | 23.0 | 28.0 | 0 | 22 |
G4, % | 0 | 3.5 | 0 | 11.0 | 0 | 5.0 | 4 |
G9, % | 2.2 | 5.3 | 10.0 | 0.6 | 18.0 | 55.0 | 14 |
G12, % | 0 | 0 | 6.2 | 0.7 | 0 | 0 | 2.0 |
M/O/U, % | 11.9 | 2.2 | 25.1 | 5.2 | 5.0 | 22.0 | 13 |
Rotavirus sampling sites and testing (method for G typing specified) and dates from the individual studies of the 6 Asian countries were as follows: In China, samples were collected from 3 sentinel hospitals in mainland China and tested (multiplex seminested reverse transcription polymerase chain reaction [RT-PCR]) from January 2006 to December 2007.16 In Hong Kong, samples were collected and tested (nested RT-PCR) from a microbiology laboratory of an acute public hospital and a government virology laboratory serving various regions over 1 year, from December 2001 to November 2002.17 In India, samples were collected from 10 representative hospitals in 7 different cities and tested (RT-PCR) at 4 laboratories in different parts of India from December 2005 to November 2007.18 In South Korea, samples were collected and tested (1-step RT-PCR) from 8 hospitals located in 3 metropolitan areas and 4 provincial regions from April 2005 to March 2007.19 In Taiwan, samples were collected from 3 sentinel hospitals in northern, central, and southern Taiwan and testing (1-step real-time RT-PCR) was conducted at the Centers for Disease Control and Prevention in Taiwan from January 2005 to December 2007.19 In Thailand, samples were collected from 6 general hospitals located throughout Thailand and tested (2-step PCR) at the Thai National Institutes of Health from 2001 to 2003 and from a community-based surveillance program from September 2001 to August 2002.
Totals for each serotype are rounded to the nearest whole number. M/O/U, mixed, other, untypeable.